Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
2.440
-0.090 (-3.56%)
At close: Sep 20, 2024, 4:00 PM
2.430
-0.010 (-0.41%)
After-hours: Sep 20, 2024, 7:59 PM EDT
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $10.59 million as of September 20, 2024. Its market cap has increased by 89.19% in one year.
Market Cap
10.59M
Enterprise Value
6.92M
1-Year Change
89.19%
Ranking
Category
Stock Price
$2.44
Market Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $56.87M to $10.59M, a decrease of -81.37%. That is a compound annual growth rate of -53.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2024 | 6.50M | 182.61% |
| Dec 29, 2023 | 2.30M | -72.29% |
| Dec 30, 2022 | 8.30M | -85.41% |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptorum Group | 12.36M |
| Sensei Biotherapeutics | 12.32M |
| Tenax Therapeutics | 12.31M |
| Streamline Health Solutions | 11.51M |
| BioRestorative Therapies | 11.45M |
| Cingulate | 11.18M |
| GlycoMimetics | 11.09M |
| Kiora Pharmaceuticals | 11.05M |